Hemophagocytic lymphohistiocytosis: Difference between revisions

Jump to navigation Jump to search
Line 46: Line 46:


===Genetics===
===Genetics===
Five genetic subtypes of the familial form of the disease (FHL1, FHL2, FHL3, FHL4, and FHL5) are described.   
Five genetic subtypes of the familial form of the disease (FHL1, FHL2, FHL3, FHL4, and FHL5) are described.   



Revision as of 03:20, 1 August 2012

Hemophagocytic lymphohistiocytosis
Light microscopic image of bone marrow showing stromal macrophages containing numerous red blood cells in their cytoplasm
ICD-10 D76.1
ICD-9 288.4
OMIM 267700 603552
DiseasesDB 31418
MeSH D051359

WikiDoc Resources for Hemophagocytic lymphohistiocytosis

Articles

Most recent articles on Hemophagocytic lymphohistiocytosis

Most cited articles on Hemophagocytic lymphohistiocytosis

Review articles on Hemophagocytic lymphohistiocytosis

Articles on Hemophagocytic lymphohistiocytosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hemophagocytic lymphohistiocytosis

Images of Hemophagocytic lymphohistiocytosis

Photos of Hemophagocytic lymphohistiocytosis

Podcasts & MP3s on Hemophagocytic lymphohistiocytosis

Videos on Hemophagocytic lymphohistiocytosis

Evidence Based Medicine

Cochrane Collaboration on Hemophagocytic lymphohistiocytosis

Bandolier on Hemophagocytic lymphohistiocytosis

TRIP on Hemophagocytic lymphohistiocytosis

Clinical Trials

Ongoing Trials on Hemophagocytic lymphohistiocytosis at Clinical Trials.gov

Trial results on Hemophagocytic lymphohistiocytosis

Clinical Trials on Hemophagocytic lymphohistiocytosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hemophagocytic lymphohistiocytosis

NICE Guidance on Hemophagocytic lymphohistiocytosis

NHS PRODIGY Guidance

FDA on Hemophagocytic lymphohistiocytosis

CDC on Hemophagocytic lymphohistiocytosis

Books

Books on Hemophagocytic lymphohistiocytosis

News

Hemophagocytic lymphohistiocytosis in the news

Be alerted to news on Hemophagocytic lymphohistiocytosis

News trends on Hemophagocytic lymphohistiocytosis

Commentary

Blogs on Hemophagocytic lymphohistiocytosis

Definitions

Definitions of Hemophagocytic lymphohistiocytosis

Patient Resources / Community

Patient resources on Hemophagocytic lymphohistiocytosis

Discussion groups on Hemophagocytic lymphohistiocytosis

Patient Handouts on Hemophagocytic lymphohistiocytosis

Directions to Hospitals Treating Hemophagocytic lymphohistiocytosis

Risk calculators and risk factors for Hemophagocytic lymphohistiocytosis

Healthcare Provider Resources

Symptoms of Hemophagocytic lymphohistiocytosis

Causes & Risk Factors for Hemophagocytic lymphohistiocytosis

Diagnostic studies for Hemophagocytic lymphohistiocytosis

Treatment of Hemophagocytic lymphohistiocytosis

Continuing Medical Education (CME)

CME Programs on Hemophagocytic lymphohistiocytosis

International

Hemophagocytic lymphohistiocytosis en Espanol

Hemophagocytic lymphohistiocytosis en Francais

Business

Hemophagocytic lymphohistiocytosis in the Marketplace

Patents on Hemophagocytic lymphohistiocytosis

Experimental / Informatics

List of terms related to Hemophagocytic lymphohistiocytosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Synonyms and keywords: Hemophagocytic syndrome, Familial histiocytic reticulosis, Hemophagocytic lymphohistiocytosis - familial, Erythrophagocytic lymphohistiocytosis - familial, Familial haemophagocytic lymphohistiocytosis

Overview

Hemophagocytic lymphohistiocytosis (HLH) is an uncommon hematologic disorder in which the immune system produces too many activated immune cells (lymphocytes) called T cells, natural killer cells, B cells, and macrophages (histiocytes). Excessive amounts of immune system proteins called cytokines are also produced.

Classification

HLH primarily categorized as

  • Familial (primary) hemophagocytic lymphohistiocytosis (FHL)
  • Secondary HLH (SHLH)

Familial forms

FHL, an autosomal recessive disorder, is invariably fatal when untreated. It is associated with defective triggering of apoptosis and reduced cytotoxic activity, resulting in a widespread accumulation of T lymphocytes and activated macrophages.

There are four types, and each is associated with a specific gene:

Familial hemophagocytic lymphohistiocytosis has an autosomal recessive pattern of inheritance.


Pathophysiology

Excessive production of too many activated immune cells (lymphocytes) called T cells, natural killer cells, B cells, and macrophages (histiocytes) and cytokines by the immune system causes symptoms and damages liver and spleen and causes these organs to enlarge. Familial hemophagocytic lymphohistiocytosis also destroys blood-producing cells in the bone marrow, a process called hemophagocytosis. As a result, affected individuals have low numbers of red blood cells (anemia) and a reduction in the number of blood cells involved in clotting (platelets). A reduction in platelets may cause easy bruising and abnormal bleeding.

The brain may also be affected in familial hemophagocytic lymphohistiocytosis causing various symptoms and complications.


Genetics

Five genetic subtypes of the familial form of the disease (FHL1, FHL2, FHL3, FHL4, and FHL5) are described.

The five subtypes of FHL are each associated with a specific gene:

  • FHL1 - HPLH1
  • FHL2 - PRF1 (Perforin)
  • FHL3 - UNC13D (Munc13-4)
  • FHL4 - STX11 (Syntaxin 11)
  • FHL5 – STXBP2 (Syntaxin binding protein 2)/UNC18-2

Molecular genetic testing for four of the causative genes, PRF1 (FHL2), UNC13D (FHL3), STX11 (FHL4), and STXBP2 (FHL5), is available on a clinical basis.

Microscopic Pathology

Micrograph showing red blood cells within macrophages. H&E stain

Epidemiology and Demographics

  • Familial hemophagocytic lymphohistiocytosis occurs in approximately 2 in 100,000 individuals worldwide.
  • Signs and symptoms of familial hemophagocytic lymphohistiocytosis usually become apparent during infancy, although occasionally they appear later in life. They usually occur when the immune system launches an exaggerated response to an infection, but may also occur in the absence of infection.
  • Gender distribution is equal.

Natural History, Complications and Prognosis

  • Without treatment, most people with familial hemophagocytic lymphohistiocytosis survive only a few months.
  • Complications include

Diagnosis

History

Inquiry about family history may help diagnose the familial forms of Hemophagocytic lymphohistiocytosis.

Symptoms

Symptoms of FHL are usually evident within the first few months of life and may even develop in utero.

References

  1. Fisman DN (2000). "Hemophagocytic syndromes and infection". Emerging Infect. Dis. 6 (6): 601–608. PMID 11076718.

External links


Template:Hematology


Template:WikiDoc Sources

  1. Henter JI, Samuelsson-Horne A, Aricò M; et al. (2002). "Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation". Blood. 100 (7): 2367–2373. doi:10.1182/blood-2002-01-0172. PMID 12239144.